Provectus Biopharmaceuticals, Inc. SEC filings PVCT
Provectus Biopharmaceuticals, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jul 28, 2004. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 1, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Apr 30, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 20, 2026 | Apr 20, 2026 |
| DEFA14A | Additional proxy material | Jun 18, 2025 | — |
| DEFA14A | Additional proxy material | May 1, 2025 | — |
| DEF 14A | Proxy statement | May 1, 2025 | Apr 30, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Jun 20, 2024 | — |
| DEFA14A | Additional proxy material | May 6, 2024 | — |
| DEF 14A | Proxy statement | May 6, 2024 | May 6, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 26, 2024 | Apr 26, 2024 |
| DEFA14A | Additional proxy material | Jun 21, 2023 | — |
| DEFA14A | Additional proxy material | May 1, 2023 | — |
| DEF 14A | Proxy statement | May 1, 2023 | May 1, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 21, 2023 | Apr 21, 2023 |
| DEFA14A | Additional proxy material | Jun 22, 2022 | — |
| DEFA14A | Additional proxy material | Jun 6, 2022 | — |
| DEFA14A | Additional proxy material | May 26, 2022 | — |
| DEFA14A | Additional proxy material | May 19, 2022 | — |
| DEFA14A | Additional proxy material | Apr 29, 2022 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Apr 29, 2022 |
| PRE 14A | Preliminary proxy statement | Apr 19, 2022 | Apr 19, 2022 |
| DEFA14A | Additional proxy material | Apr 29, 2021 | — |
| DEF 14A | Proxy statement | Apr 29, 2021 | Apr 29, 2021 |
| DEFA14A | Additional proxy material | Apr 28, 2020 | — |
| DEF 14A | Proxy statement | Apr 28, 2020 | Apr 28, 2020 |
| DEFA14A | Additional proxy material | May 14, 2019 | — |
| DEF 14A | Proxy statement | May 14, 2019 | May 14, 2019 |
| DEFA14A | Additional proxy material | Apr 30, 2018 | — |
| DEF 14A | Proxy statement | Apr 30, 2018 | Apr 30, 2018 |
| DEF 14A | Proxy statement | Apr 27, 2017 | May 30, 2017 |
| PRE 14A | Preliminary proxy statement | Apr 17, 2017 | May 30, 2017 |
| DEFA14A | Additional proxy material | Jan 27, 2017 | — |
| DEFA14A | Additional proxy material | Nov 18, 2016 | — |
| DEF 14A | Proxy statement | Nov 2, 2016 | Nov 28, 2016 |
| PRE 14A | Preliminary proxy statement | Oct 5, 2016 | Nov 14, 2016 |
| DEF 14A | Proxy statement | Apr 29, 2016 | Jun 16, 2016 |
| DEF 14A | Proxy statement | Sep 1, 2015 | Oct 1, 2015 |
| PRE 14A | Preliminary proxy statement | Aug 21, 2015 | Oct 1, 2015 |
| DEF 14A | Proxy statement | Apr 30, 2015 | Jun 19, 2015 |
| DEF 14A | Proxy statement | Apr 30, 2014 | Jun 16, 2014 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2014 | Jun 16, 2014 |
| DEF 14A | Proxy statement | Nov 15, 2013 | Dec 16, 2013 |
| PRE 14A | Preliminary proxy statement | Nov 5, 2013 | Dec 16, 2013 |
| DEF 14A | Proxy statement | Apr 30, 2013 | Jun 27, 2013 |
| PRE 14A | Preliminary proxy statement | Apr 19, 2013 | Jun 27, 2013 |
| DEF 14A | Proxy statement | Apr 30, 2012 | Jun 28, 2012 |
| DEF 14A | Proxy statement | Jul 19, 2011 | Aug 26, 2011 |
| PRE 14A | Preliminary proxy statement | Jul 8, 2011 | Aug 26, 2011 |
| DEF 14A | Proxy statement | May 2, 2011 | Jun 23, 2011 |
| PRE 14A | Preliminary proxy statement | Apr 22, 2011 | Jun 23, 2011 |
| DEF 14A | Proxy statement | Apr 30, 2010 | Apr 29, 2010 |
| DEF 14A | Proxy statement | Dec 1, 2009 | Dec 1, 2009 |
| PRE 14A | Preliminary proxy statement | Nov 19, 2009 | Nov 17, 2009 |
| DEF 14A | Proxy statement | Apr 30, 2009 | Apr 29, 2008 |
| DEF 14A | Proxy statement | Apr 29, 2008 | Apr 29, 2008 |
| DEF 14A | Proxy statement | Apr 27, 2007 | Apr 27, 2007 |
| DEF 14A | Proxy statement | Apr 28, 2006 | Apr 26, 2006 |
| DEF 14A | Proxy statement | Apr 21, 2005 | Apr 21, 2005 |
Showing 59 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PVCT (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Knoxville, TN
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 315545
- Former names
- PROVECTUS PHARMACEUTICALS INC (until Dec 18, 2013); PROVECTUS PHARMACEUTICAL INC (until May 15, 2002); ZAMAGE DIGITAL IMAGING INC (until Apr 1, 2002); SPM GROUP INC (until Nov 14, 2001)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.